AKBA
Akebia Therapeutics, Inc.Closed0.7700−0.02 −2.56%USD
NasdaqCM · as of Oct 13, 16:00 ET · 15m delayAfter hours 0.7740 +0.52%
Open
0.8000
Prev close
0.7902
Day range
0.76550.8049
52-week range
0.76553.20
Volume
6.50M1.03×
Mkt cap
213.37M
P/E ttm
—
Fwd P/E
-2.14
EPS ttm
-0.1200
Div yield
0.00%
Earnings
Aug 5, 2026
From 52w high
−75.94%
AKBA earnings and estimates
AKBA Next Report
Yahoo Finance · Nasdaq
Report date
Mon, Nov 9
After the close
EPS consensus
$−0.03
range −0.04 – −0.02
EPS growth vs year ago
0.0%
year ago 0.00
Revenue consensus
$46.94M
−20.1% vs year ago
Options-implied move
±62.3%
by Nov 20 · ATM straddle
Past 4 reactions
±18.4%
average move · beat 2 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 5, 2026 AMC | −0.03 | −0.03 | −3.20% | $49.13M | −26.0% | −30.8% |
| Mar '26 | May 7, 2026 BMO | −0.03 | −0.02 | −50.00% | $53.54M | −20.3% | −20.3% |
| Dec '25 | Feb 26, 2026 BMO | −0.05 | −0.06 | +16.67% | $57.62M | +9.1% | +3.3% |
| Sep '25 | Nov 10, 2025 BMO | 0.00 | −0.01 | +100.00% | $58.77M | −18.1% | −18.1% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.03 | −0.04−0.02 | 0.0% | $46.94M | −20.1% | −0.04 +25.0% | −0.03 0.0% | 1 / 0 |
| Next quarter Dec 2026 | −0.03 | −0.05−0.01 | +40.0% | $48.19M | −16.4% | −0.02 −50.0% | −0.02 −50.0% | 0 / 1 |
| Current year Dec 2026 | −0.16 | — | −700.0% | $197.85M | −16.2% | −0.10 −52.4% | −0.10 −52.4% | 0 / 1 |
| Next year Dec 2027 | −0.36 | −0.39−0.33 | −125.0% | $132.51M | −33.0% | −0.20 −80.0% | −0.19 −89.5% | 0 / 1 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.03 | −0.04−0.02 | 2 | 0 / 0 |
| Dec 2026 | −0.04 | −0.05−0.03 | 2 | 0 / 0 |
| Mar 2027 | −0.09 | — | 1 | 0 / 0 |
| Jun 2027 | −0.09 | — | 1 | 0 / 0 |
| Sep 2027 | −0.08 | — | 1 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −0.14 | −0.16−0.12 | 2 | 0 / 0 |
| Dec 2027 | −0.27 | −0.33−0.21 | 2 | 0 / 0 |
| Dec 2028 | −0.12 | −0.16−0.07 | 2 | 0 / 0 |
| Dec 2029 | −0.06 | −0.150.04 | 2 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.